Pharmaceutical Company Incentive Issues
- companies which currently produce morbidity would be incentivised to claim money to treat it — but that’s not a problem, is it?
- companies would be incentivised to produce morbidity in anticipation of the scheme coming into effect — that IS a problem
- companies would be incentivised to misreport their outcomes — but presumably could be made to police each other
- companies may have no incentive to eradicated eradicable diseases (Michael Selgelid)
